Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072007
Status:
COMPLETED
Last Update Posted:
2012-05-15
First Post:
2003-11-04
Brief Title:
Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL
Sponsor:
Organization:
Swiss Group for Clinical Cancer Research